Dr. Morris is the Chief Scientific Officer and leads Research and Development efforts supporting Solid’s neuromuscular programs.
Dr. Morris has served as Solid’s Chief Scientific Officer since June 2017, and previously served as Solid’s Senior Vice President of Research and Development from September 2015 to June 2017. Prior to joining Solid, Dr. Morris held various leadership positions within the Rare Disease Research Unit at Pfizer, Inc. (“Pfizer”) from January 2010 to August 2015, including serving as a Senior Director, Director and Senior Principal Scientist. Prior to Pfizer, Dr. Morris held various positions within the Tissue Repair unit at Wyeth Pharmaceuticals, Inc., a pharmaceutical company acquired by Pfizer. Dr. Morris was an Assistant Professor at Boston University School of Medicine and a founding faculty member of the Muscle and Aging Research Unit. He is also co-founder and a member of the Board of Directors of Breed Nutrition Inc. Dr. Morris holds a B.A. in Biology from Franklin Pierce College and a Ph.D. in Physiology from UCLA.